Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Study Treatment	STARTED	Arm A (Genomically Directed Monotherapy)	71
Study Treatment	STARTED	Control Arm B (Observation/Standard Therapy)	122
Study Treatment	COMPLETED	Arm A (Genomically Directed Monotherapy)	45
Study Treatment	COMPLETED	Control Arm B (Observation/Standard Therapy)	110
Study Treatment	NOT COMPLETED	Arm A (Genomically Directed Monotherapy)	26
Study Treatment	NOT COMPLETED	Control Arm B (Observation/Standard Therapy)	12
Follow up	STARTED	Arm A (Genomically Directed Monotherapy)	70
Follow up	STARTED	Control Arm B (Observation/Standard Therapy)	122
Follow up	COMPLETED	Arm A (Genomically Directed Monotherapy)	3
Follow up	COMPLETED	Control Arm B (Observation/Standard Therapy)	9
Follow up	NOT COMPLETED	Arm A (Genomically Directed Monotherapy)	67
Follow up	NOT COMPLETED	Control Arm B (Observation/Standard Therapy)	113

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02101385/flow